Insight into understanding IDH mediated disease

[News]

Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in cancer metabolism, announced today the publication of a new study that provides further evidence of the link between a mutated metabolic enzyme and acute myeloid leukemia (AML), one of the most common types of leukemia in adults.

More... (http://www.news-medical.net/news/20120706/Insight-into-understanding-IDH-mediated-disease.aspx)